Healthcare provider profile · identity verified

Nicole M. Pashek, ARNP

Nurse Practitioner · THE DALLES, OR · NPI 1043241144

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	399	98
Levothyroxine Sodium	Levothyroxine Sodium	385	71
Amlodipine Besylate	Amlodipine Besylate	329	66
Losartan Potassium	Losartan Potassium	323	77
Metoprolol Succinate	Metoprolol Succinate	291	67
Pantoprazole Sodium	Pantoprazole Sodium	273	61
Lisinopril	Lisinopril	267	55
Gabapentin	Gabapentin	264	68
Potassium Chloride	Potassium Chloride	261	59
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	230	41
Omeprazole	Omeprazole	229	55
Rosuvastatin Calcium	Rosuvastatin Calcium	183	45
Donepezil Hcl	Donepezil Hcl	179	30
Furosemide	Furosemide	179	42
Tamsulosin Hcl	Tamsulosin Hcl	179	37
Sertraline Hcl	Sertraline Hcl	169	30
Warfarin Sodium	Warfarin Sodium	163	15
Eliquis	Apixaban	156	27
Metformin Hcl Er	Metformin Hcl	147	34
Hydrochlorothiazide	Hydrochlorothiazide	135	35
Oxycodone Hcl	Oxycodone Hcl	134	25
Spironolactone	Spironolactone	116	25
Trazodone Hcl	Trazodone Hcl	116	27
Mirtazapine	Mirtazapine	115	28
Simvastatin	Simvastatin	112	21
Albuterol Sulfate Hfa	Albuterol Sulfate	110	32
Duloxetine Hcl	Duloxetine Hcl	106	26
Metoprolol Tartrate	Metoprolol Tartrate	103	20
Lorazepam	Lorazepam	95	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	19
Carvedilol	Carvedilol	89	22
Clopidogrel	Clopidogrel Bisulfate	87	18
Xarelto	Rivaroxaban	78	12
Cephalexin	Cephalexin	75	56
Pregabalin	Pregabalin	75	suppressed
Citalopram Hbr	Citalopram Hydrobromide	72	12
Torsemide	Torsemide	71	18
Fluticasone Propionate	Fluticasone Propionate	68	27
Buspirone Hcl	Buspirone Hcl	62	13
Quetiapine Fumarate	Quetiapine Fumarate	59	suppressed
Alendronate Sodium	Alendronate Sodium	57	15
Zolpidem Tartrate	Zolpidem Tartrate	57	suppressed
Jardiance	Empagliflozin	55	13
Allopurinol	Allopurinol	53	11
Baclofen	Baclofen	52	suppressed
Pravastatin Sodium	Pravastatin Sodium	50	suppressed
Metformin Hcl	Metformin Hcl	48	17
Mupirocin	Mupirocin	48	16
Memantine Hcl	Memantine Hcl	47	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	44	13
Irbesartan	Irbesartan	43	suppressed
Montelukast Sodium	Montelukast Sodium	43	14
Tramadol Hcl	Tramadol Hcl	42	suppressed
Ozempic	Semaglutide	41	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	41	22
Famotidine	Famotidine	39	suppressed
Latanoprost	Latanoprost	39	suppressed
Ipratropium Bromide	Ipratropium Bromide	38	suppressed
Propranolol Hcl	Propranolol Hcl	38	suppressed
Finasteride	Finasteride	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	35	17
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Prednisone	Prednisone	34	16
Clonazepam	Clonazepam	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Myrbetriq	Mirabegron	30	suppressed
Atenolol	Atenolol	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Olanzapine	Olanzapine	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Naproxen	Naproxen	28	suppressed
Clotrimazole	Clotrimazole	27	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Entresto	Sacubitril/Valsartan	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Fluconazole	Fluconazole	23	16
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	22	suppressed
Azithromycin	Azithromycin	22	18
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Bupropion Xl	Bupropion Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	17	14
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Lactulose	Lactulose	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Oxycontin	Oxycodone Hcl	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Estradiol	Estradiol	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Testosterone	Testosterone	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Hydroxyurea	Hydroxyurea	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	11
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Nitroglycerin	Nitroglycerin	13	11
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Galantamine Er	Galantamine Hbr	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Pimecrolimus	Pimecrolimus	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error